Australia · Delayed Price · Currency is AUD Compumedics Statistics
Total Valuation
Compumedics has a market cap or net worth of AUD 50.94 million. The enterprise value is 58.90 million.
| Market Cap | 50.94M |
| Enterprise Value | 58.90M |
Important Dates
The next estimated earnings date is Friday, September 4, 2026.
| Earnings Date | Sep 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Compumedics has 199.76 million shares outstanding. The number of shares has increased by 13.67% in one year.
| Current Share Class | 199.76M |
| Shares Outstanding | 199.76M |
| Shares Change (YoY) | +13.67% |
| Shares Change (QoQ) | -39.70% |
| Owned by Insiders (%) | 53.77% |
| Owned by Institutions (%) | 3.74% |
| Float | 71.99M |
Valuation Ratios
The trailing PE ratio is 255.00 and the forward PE ratio is 12.14.
| PE Ratio | 255.00 |
| Forward PE | 12.14 |
| PS Ratio | 0.82 |
| PB Ratio | 2.24 |
| P/TBV Ratio | 2.24 |
| P/FCF Ratio | 7.93 |
| P/OCF Ratio | 7.71 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.50, with an EV/FCF ratio of 9.17.
| EV / Earnings | 275.25 |
| EV / Sales | 0.95 |
| EV / EBITDA | 10.50 |
| EV / EBIT | 17.27 |
| EV / FCF | 9.17 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.23 |
| Quick Ratio | 0.68 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 2.52 |
| Debt / FCF | 2.20 |
| Interest Coverage | 2.26 |
Financial Efficiency
Return on equity (ROE) is 0.96% and return on invested capital (ROIC) is 1.43%.
| Return on Equity (ROE) | 0.96% |
| Return on Assets (ROA) | 3.84% |
| Return on Invested Capital (ROIC) | 1.43% |
| Return on Capital Employed (ROCE) | 11.99% |
| Weighted Average Cost of Capital (WACC) | 5.14% |
| Revenue Per Employee | 353,583 |
| Profits Per Employee | 1,223 |
| Employee Count | 175 |
| Asset Turnover | 1.12 |
| Inventory Turnover | 2.07 |
Taxes
In the past 12 months, Compumedics has paid 1.45 million in taxes.
| Income Tax | 1.45M |
| Effective Tax Rate | 87.12% |
Stock Price Statistics
The stock price has decreased by -10.53% in the last 52 weeks. The beta is 0.35, so Compumedics's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | -10.53% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.31 |
| Relative Strength Index (RSI) | 57.63 |
| Average Volume (20 Days) | 57,977 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Compumedics had revenue of AUD 61.88 million and earned 214,000 in profits. Earnings per share was 0.00.
| Revenue | 61.88M |
| Gross Profit | 32.60M |
| Operating Income | 3.41M |
| Pretax Income | 1.66M |
| Net Income | 214,000 |
| EBITDA | 4.82M |
| EBIT | 3.41M |
| Earnings Per Share (EPS) | 0.00 |
Balance Sheet
The company has 6.15 million in cash and 14.11 million in debt, with a net cash position of -7.96 million or -0.04 per share.
| Cash & Cash Equivalents | 6.15M |
| Total Debt | 14.11M |
| Net Cash | -7.96M |
| Net Cash Per Share | -0.04 |
| Equity (Book Value) | 22.71M |
| Book Value Per Share | 0.14 |
| Working Capital | 6.46M |
Cash Flow
In the last 12 months, operating cash flow was 6.61 million and capital expenditures -181,000, giving a free cash flow of 6.42 million.
| Operating Cash Flow | 6.61M |
| Capital Expenditures | -181,000 |
| Depreciation & Amortization | 1.41M |
| Net Borrowing | 2.26M |
| Free Cash Flow | 6.42M |
| FCF Per Share | 0.03 |
Margins
Gross margin is 52.69%, with operating and profit margins of 5.51% and 0.35%.
| Gross Margin | 52.69% |
| Operating Margin | 5.51% |
| Pretax Margin | 2.69% |
| Profit Margin | 0.35% |
| EBITDA Margin | 7.78% |
| EBIT Margin | 5.51% |
| FCF Margin | 10.38% |
Dividends & Yields
Compumedics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.67% |
| Shareholder Yield | -13.67% |
| Earnings Yield | 0.42% |
| FCF Yield | 12.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Compumedics has an Altman Z-Score of 2.07 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.07 |
| Piotroski F-Score | 6 |